1.0Neo Pharma Technologieshttps://neopharmatechnologies.com/ms/adminhttps://neopharmatechnologies.com/ms/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="QWtE8UORZ0"><a href="https://neopharmatechnologies.com/ms/press-releases/">Siaran Akhbar</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://neopharmatechnologies.com/ms/press-releases/embed/#?secret=QWtE8UORZ0" width="600" height="338" title="“Siaran Akhbar” — Neo Pharma Technologies" data-secret="QWtE8UORZ0" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /*! This file is auto-generated */ !function(c,l){"use strict";var e=!1,o=!1;if(l.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(/[^a-zA-Z0-9]/.test(t.secret));else{for(var r,s,a,i=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=0;o<n.length;o++)n[o].style.display="none";for(o=0;o<i.length;o++)if(r=i[o],e.source!==r.contentWindow);else{if(r.removeAttribute("style"),"height"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if("link"===t.message)if(s=l.createElement("a"),a=l.createElement("a"),s.href=r.getAttribute("src"),a.href=t.value,a.host===s.host)if(l.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener("message",c.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",t,!1),c.addEventListener("load",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf("MSIE 10"),a=!!navigator.userAgent.match(/Trident.*rv:11\./),i=l.querySelectorAll("iframe.wp-embedded-content"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute("data-secret")))r=Math.random().toString(36).substr(2,10),t.src+="#?secret="+r,t.setAttribute("data-secret",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute("security"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:"ready",secret:r},"*")}}}}(window,document); </script> Siaran Akhbar Neopharma Technologies telah diiktiraf sebagai 100 syarikat Teknologi Penjagaan Kesihatan Teratas pada tahun 2021. Mendahului dalam Ujian Penyalahgunaan-Dadah Siaran Akhbar pada 7hb September 2021 Neopharma Technologies Ltd ialah pemilik dan pengendali peranti ujian Penyalahgunaan Dadah yang dipatenkan di peringkat global, mempunyai tanda dagangan dan memenangi anugerah dan platform Pengurusan Sumber Perusahaan: TamperLoks DataVault. […]